跳至主要内容
临床试验/NCT06901492
NCT06901492尚未招募不适用

The Diagnostic Application of PSMA PET/MR in Patients with PSA <20 Ng/ml and Initial Negative Prostate Biopsy

Nanjing First Hospital, Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
Biospy outcome

研究概览

简要总结

The present study is designed to explore the value of targeted puncture guided by PSMA PET/CT or mpMRI in the diagnosis of patients with low PSA and initial negative prostate biopsy

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Age ≥40 years, male;
  • •Serum PSA level 4-20 ng/mL;
  • •Serum PSA level 4-20 ng/mL;
  • •No contraindications to PSMA-PET/CT or MRI;
  • •Signed informed consent.

排除标准

  • •Serum PSA >20 ng/mL;
  • •History of prostate surgery/radiotherapy;
  • •Acute prostatitis;
  • •Coagulation disorders or active infection;
  • •Severe internal/external hemorrhoids, perianal, rectal, or gluteal lesions;
  • •Allergy to local anesthetics;
  • •Inability to tolerate the biopsy procedure.

研究组 & 干预措施

PET+/mpMRI+ group

Experimental

Patients in this group will undergo 68Ga-PSMA PET/mpMRI imaging, and the results show positive findings on both PSMA PET and mpMRI. These patients will undergo prostate biopsy guided by PSMA PET/CT.

干预措施: Prostate biopsy guided by PSMA PET/CT (Diagnostic Test)

PET+/mpMRI- group

Experimental

Patients in this group will undergo 68Ga-PSMA PET/mpMRI imaging, and the results show positive findings on PSMA PET and negative on mpMRI. These patients will undergo prostate biopsy guided by PSMA PET/CT.

干预措施: Prostate biopsy guided by PSMA PET/CT (Diagnostic Test)

PET-/mpMRI+ group

Active Comparator

Patients in this group will undergo 68Ga-PSMA PET/mpMRI imaging, and the results show negative findings on PSMA PET and positive on mpMRI. These patients will undergo prostate biopsy guided by mpMRI and US.

干预措施: Prostate biopsy guided by mpMRI/US (Diagnostic Test)

PET-/mpMRI- group

Placebo Comparator

Patients in this group will undergo 68Ga-PSMA PET/mpMRI imaging, and the results show negative findings on both PSMA PET and mpMRI. These patients will undergo systematic prostate biopsy.

干预措施: Systematic prostate biopsy (Diagnostic Test)

结局指标

主要结局

Biospy outcome

时间窗: 12 months

Compare the diagnostic value (including sensitivity, specificity, NPV and PPV) between puncture methods and set up a diagnostic model.

次要结局

  • Duration of puncture operation(12 months)
  • Patient's pain level(12 months)
  • Blood loss(12 months)
  • Complication(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验